Least Squares Support Vector Machine Classifiers
Neural Processing Letters
An introduction to support Vector Machines: and other kernel-based learning methods
An introduction to support Vector Machines: and other kernel-based learning methods
Optimal control by least squares support vector machines
Neural Networks
Use of Support Vector Machines and Neural Network in Diagnosis of Neuromuscular Disorders
Journal of Medical Systems
Pattern Recognition Letters
Hi-index | 0.01 |
In this paper we propose a semiparametric mixed-effect least squares support vector machine (LS-SVM) regression model for the analysis of pharmacokinetic (PK) and pharmacodynamic (PD) data. We also develop the generalized cross-validation (GCV) method for choosing the hyperparameters which affect the performance of the proposed LS-SVM. The performance of the proposed LS-SVM is compared with those of NONMEM and the regular semiparametric LS-SVM via four measures, which are mean squared error (MSE), mean absolute error (MAE), mean relative absolute error (MRAE) and mean relative prediction error (MRPE). Through paired-t test statistic we find that the absolute values of four measures of the proposed LS-SVM are significantly smaller than those of NONMEM for PK and PD data. We also investigate the coefficient of determinations R^2's of predicted and observed values. The R^2's of NONMEM are 0.66 and 0.59 for PK and PD data, respectively, while the R^2's of the proposed LS-SVM are 0.94 and 0.96. Through cross validation technique we also find that the proposed LS-SVM shows better generalization performance than the regular semiparametric LS-SVM for PK and PD data. These facts indicate that the proposed LS-SVM is an appealing tool for analyzing PK and PD data.